Transient hypothyroidism after iodine-131 therapy for Graves' disease

被引:0
|
作者
Gómez, N [1 ]
Gómez, JM
Villabona, C
Soler, J
机构
[1] Ciutat Sanitaria, Dept Endocrinol, Barcelona, Spain
[2] Univ Bellvitge, Barcelona, Spain
关键词
D O I
10.1046/j.1365-2265.1998.00472.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:526 / 527
页数:2
相关论文
共 50 条
  • [21] A rare case of iododerma after therapy with oral Iodine-131
    Lazaga, Francisco
    Agarwal, Anshul
    Erdman, William
    Oz, Orhan
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [22] Conception after iodine-131 therapy for differentiated thyroid cancer
    Ayala, C
    Navarro, E
    Rodriguez, JR
    Silva, H
    Venegas, E
    Astorga, R
    THYROID, 1998, 8 (11) : 1009 - 1011
  • [24] Influence of Propylthiouracil and Methimazole Pre-treatment on the Outcome of Iodine-131 Therapy in Hyperthyroid Patients with Graves' Disease
    Shi, G-M
    Xu, Q.
    Zhu, C-Y
    Yang, Y-L
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (02) : 576 - 582
  • [25] The clinical analysis of 50 pregnant women with a history of iodine-131 treatment for Graves' disease
    Guan, Liang
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [26] Iodine-131 uptake and turnover rate vary over short intervals in Graves' disease
    Van Isselt, JW
    De Klerk, JMH
    Koppeschaar, HPF
    Van Rijk, PP
    NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (07) : 609 - 616
  • [27] Influence of an additional application of iodine-127 on the pharmacokinetics of radioactive iodine-131 during a radioiodine therapy in patients with Graves' disease.
    Moka, D
    Reinholz, U
    Eschner, W
    Wellner, U
    Schicha, H
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 332P - 333P
  • [28] Does the dose of iodine-131 influence the incidence of Graves' ophthalmopathy?
    Khiyani, Neeraj
    Dadparvar, Simin
    Gish, Aaron
    Intenzo, Charles M.
    Malmud, Leon S.
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (05) : 455 - 460
  • [30] Iodine-131 and Iodine-131-Meta-iodobenzylguanidine Dosimetry in Cancer Therapy
    Flux, Glenn
    Leek, Francesca
    Gape, Paul
    Gear, Jonathan
    Taprogge, Jan
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (02) : 167 - 177